Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImmuPharma ( (GB:IMM) ) just unveiled an update.
ImmuPharma has announced a change in its major holdings, with Lanstead Capital Investors LP reducing its stake from 16.13% to 12.99% of voting rights. This adjustment in holdings may influence the company’s shareholder dynamics and could have implications for its strategic decisions and market perception.
More about ImmuPharma
ImmuPharma is a pharmaceutical company that focuses on the development and commercialization of innovative drugs. The company operates in the biotech industry, primarily targeting unmet medical needs through its proprietary drug development programs.
Average Trading Volume: 3,152,205
Technical Sentiment Signal: Hold
Current Market Cap: £13.27M
Find detailed analytics on IMM stock on TipRanks’ Stock Analysis page.